T. Yamamoto et al., EFFECT OF DL-SODIUM LACTATE INFUSION ON EXCRETION OF PURINE-BASES ANDOXYPURINOL, International journal of clinical pharmacology, therapy and toxicology, 31(12), 1993, pp. 588-592
To investigate whether or not DL-sodium lactate inhibits the renal exc
retion of purine bases and oxypurinol, we administered physiological s
aline containing 0.2 mol DL-sodium lactate to 7 normal subjects intrav
enously. DL-sodium lactate infusion decreased the urinary excretion an
d the fractional clearance of uric acid, xanthine and oxypurinol, but
the fractional clearance of hypoxanthine was not affected. These resul
ts suggested that the implications of DL-sodium lactate-induced hyperu
ricemia must be considered in patients with gout on its long term and
high dose administration, and that the implications of DL-sodium lacta
te-induced prolongation of half-life of oxypurinol must be considered
in hyperuricemic patients treated with allopurinol. However, since the
high dose and long term administration of DL-sodium lactate is clinic
ally rare, the effect of DL-sodium lactate infusion on the urinary exc
retion of uric acid, xanthine and oxypurinol may not be clinically imp
ortant.